Premium
Liver transplant for metastatic pancreatoblastoma: 7‐year event‐free survival after chemotherapy, pancreatectomy, complete hepatectomy, and liver transplant
Author(s) -
Ghaffarian A. A.,
Book L.,
Meyers R. L.
Publication year - 2018
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/petr.13098
Subject(s) - medicine , hepatectomy , vincristine , chemotherapy , pancreatectomy , surgery , metastasis , liver tumor , pancreas , regimen , liver transplantation , pancreatic tumor , doxorubicin , cyclophosphamide , transplantation , cancer , resection , pancreatic cancer , hepatocellular carcinoma
Pancreatoblastoma is a rare malignant tumor in children. Surgical resection of the tumor is necessary for cure; however, due to its aggressive nature, it is often unresectable at presentation due to tumor size, local invasion, and/or metastasis. Because it is a rare tumor, there is currently no standard treatment regimen. We report a case of a 4‐year‐old boy who presented with metastatic pancreatoblastoma with multiple large metastases involving all four sectors of the liver. We began treatment with chemotherapy (cisplatin, 5FU, vincristine, and doxorubicin), which significantly reduced the tumor burden in both the pancreas and liver. We then performed a staged subtotal pancreatectomy, complete hepatectomy, and living donor left lateral segment liver transplant. This was followed by postoperative adjuvant chemotherapy. Our patient is alive and healthy and has now been tumor‐free for 7 years with no tumor relapse.